About
EARLY Labs is a Bio-Tech company, operating in the field of Volatile Organic Compound based diagnostics. The company is developing a revolutionary multi-cancer test platform, currently focusing on lung cancer, detecting lung cancer in urine samples, from it's earliest stages – with groundbreaking 90% stage I sensitivity and specificity results. By Q4 2024 the platform will be calibrated to run Colon testing as well, and other cancer types to follow. Simplicity of the test, which can be done at home or at pharmacies, using a urine collection kit, is expected to break existing uptake barriers such as invasiveness, radiation, long waiting lists, inconvenience and more, and completely change the cancer screening paradigm.
Funding history · 1 round · $4.0M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is EARLY Labs' primary focus in diagnostics?
- EARLY Labs is a Bio-Tech company focused on Volatile Organic Compound (VOC) based diagnostics, developing a multi-cancer test platform.
- What is the current primary application of EARLY Labs' diagnostic platform?
- EARLY Labs' platform is currently focused on detecting lung cancer in urine samples, demonstrating 90% stage I sensitivity and specificity results.
- When does EARLY Labs plan to expand its platform to include colon cancer testing?
- By Q4 2024, EARLY Labs plans to calibrate its platform to run colon cancer testing, with other cancer types to follow.
- What is the total funding EARLY Labs has raised to date?
- EARLY Labs has raised a total of $4,000,000 in funding, according to startupim data.
- When was EARLY Labs founded and what was its initial funding round?
- EARLY Labs was founded in July 2020 and secured a Seed round of $4,000,000 in the same month from undisclosed investor(s).
- How many employees does EARLY Labs currently have?
- EARLY Labs currently has 6 employees.
- What is the status of EARLY Labs' product development?
- EARLY Labs' product, the EARLY Lung Cancer Detection Urine Test, is currently in the clinical trial stage.
- What was a notable news event for EARLY Labs in February 2023?
- In February 2023, news outlets like The Times of Israel reported that EARLY Labs' lab claims to teach rats to detect lung cancer with 93% accuracy by sniffing urine.
- Who is a co-founder of EARLY Labs?
- Michal Mark Danieli is a co-founder of EARLY Labs.